Many cancer drugs remain unproven 5 years after accelerated approval, a study finds – The Associated Press
Business News Many cancer drugs remain unproven 5 years after accelerated approval, a study finds The Associated Press Half of cancer drugs given accelerated approval fail in later trials – STAT STAT Speedier drug approvals hit slowdown as FDA faces scrutiny The Associated Press Study: Many cancer drugs remain unproven 5 years after accelerated approval Pittsburgh Post-Gazette Scripps News-ProPublica […]
